Skip to main content
. 2020 Sep 3;34(5):2595–2606. doi: 10.21873/invivo.12077

Figure 4. Efficacy of JPH203 in High- and Low-body mass index (BMI) groups. (A) Progression-free survival. (B) Overall survival. BMI was divided into a High-BMI group and a Low-BMI group by the median. Black line, High-BMI group. Dotted line, Low-BMI group. CI: Confidence interval.

Figure 4